Suppr超能文献

也门伊卜省血液透析患者中乙型和丙型肝炎病毒的流行情况及相关因素

The Prevalence and Associated Factors of Hepatitis B and C Virus in Hemodialysis Patients in Ibb Governorate, Yemen.

作者信息

H Ahmed Radwan, Al-Nagar Nada, Al-Subol Ibrahim, Al-Wahbi Rehab, Al-Sabahi Manar, Al-Sabahi Mohamed, Al-Sabahi Khaled, Shomasi Asmaa, Al-Hamodi Abdulmalik

机构信息

Department of Medical Laboratory, Faculty of Medicine and Health Sciences, University of Science and Technology, Sana'a, YEM.

Nephrology Unit, Al-Thawra General Hospital, Ibb, YEM.

出版信息

Cureus. 2024 Sep 24;16(9):e70112. doi: 10.7759/cureus.70112. eCollection 2024 Sep.

Abstract

Introduction Hepatitis C virus (HCV) and hepatitis B virus (HBV) among patients receiving hemodialysis (HD) remain a major public health problem. However, information is limited about these infections among HD patients in Yemen. This study aimed to estimate the prevalence and associated risk factors of HBV and HCV infections among HD patients in the Ibb governorate, Yemen, and to identify the risk factors for infections in such patients. Methods A cross-sectional study of 374 patients with renal failure who regularly underwent HD at the Al-Thawra Hospital in Ibb city, Yemen, was performed after they agreed to participate and signed informed consent. Enzyme-linked immunoassay (ELISA) was used to test the serum levels of anti-HCV antibodies and hepatitis B surface antigen (HBsAg). Patient data (demographic characteristics and risk factors) were collected via an interview questionnaire and medical records. Logistic regression analysis and chi-square tests were used to analyze the results. Results The overall prevalence of HCV was 31% (n=116), whereas that of HBV was 6.15% (n=23). Three (0.8%) patients had both HCV and HBV. The logistic regression analysis revealed a significant association between an increased number of units of blood transfused (OR = 3.1; 95% CI: 1.7-5.6; p < 0.001), a long duration of dialysis (OR = 3.2; 95% CI: 1.9-5.2; p = 0.001), and HCV infection in HD patients. On the other hand, a history of cupping therapy (Hijama) was significantly associated (OR = 3.4; 95% CI: 1.3-8.77; p < 0.011) with HBV infection in HD patients. Conclusion HCV and HBV infections are more common among HD patients in Yemen than in most Middle Eastern countries. However, the current prevalence rates are declining compared with previously published data among Yemeni HD patients. The duration of HD and number of blood units were independent risk factors for HCV infection, and patients with a history of cupping were identified as having an increased risk of HBV infection. These findings underscore the need to implement strict infection control in HD units.

摘要

引言

在接受血液透析(HD)的患者中,丙型肝炎病毒(HCV)和乙型肝炎病毒(HBV)仍然是一个重大的公共卫生问题。然而,也门HD患者中这些感染的相关信息有限。本研究旨在估计也门伊卜省HD患者中HBV和HCV感染的患病率及相关危险因素,并确定此类患者感染的危险因素。方法:在也门伊卜市萨那医院对374例定期接受HD的肾衰竭患者进行了一项横断面研究,这些患者在同意参与并签署知情同意书后纳入研究。采用酶联免疫吸附测定(ELISA)检测血清抗HCV抗体和乙型肝炎表面抗原(HBsAg)水平。通过访谈问卷和病历收集患者数据(人口统计学特征和危险因素)。采用逻辑回归分析和卡方检验分析结果。结果:HCV的总体患病率为31%(n = 116),而HBV的患病率为6.15%(n = 23)。3例(0.8%)患者同时感染了HCV和HBV。逻辑回归分析显示,HD患者输血单位数量增加(比值比[OR]=3.1;95%置信区间[CI]:1.7 - 5.6;p < 0.001)、透析时间长(OR = 3.2;95% CI:1.9 - 5.2;p = 0.001)与HCV感染之间存在显著关联。另一方面,拔罐疗法(希贾马)史与HD患者HBV感染显著相关(OR = 3.4;95% CI:1.3 - 8.77;p < 0.011)。结论:与大多数中东国家相比,也门HD患者中HCV和HBV感染更为常见。然而,与之前发表的也门HD患者数据相比,目前的患病率正在下降。HD时间和输血量是HCV感染的独立危险因素,有拔罐史的患者被确定为HBV感染风险增加。这些发现强调了在HD单位实施严格感染控制的必要性。

相似文献

1
The Prevalence and Associated Factors of Hepatitis B and C Virus in Hemodialysis Patients in Ibb Governorate, Yemen.
Cureus. 2024 Sep 24;16(9):e70112. doi: 10.7759/cureus.70112. eCollection 2024 Sep.
2
Epidemiology of viral hepatitis B and C infections in ibb city, yemen.
Hepat Mon. 2012 Jul;12(7):460-2. doi: 10.5812/hepatmon.6140. Epub 2012 Jul 30.
7
Hepatitis and HIV infection during haemodialysis.
J Indian Med Assoc. 2001 Apr;99(4):194-9, 203, 213.
8
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center.
Cureus. 2023 Jul 12;15(7):e41769. doi: 10.7759/cureus.41769. eCollection 2023 Jul.

本文引用的文献

1
WHO's 2024 global hepatitis report.
Lancet Infect Dis. 2024 Jun;24(6):e362-e363. doi: 10.1016/S1473-3099(24)00307-4.
3
Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.
PLoS One. 2024 Feb 8;19(2):e0284169. doi: 10.1371/journal.pone.0284169. eCollection 2024.
4
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center.
Cureus. 2023 Jul 12;15(7):e41769. doi: 10.7759/cureus.41769. eCollection 2023 Jul.
5
Global epidemiology of HBV infection among hemodialysis patients: A systematic review and meta-analysis.
Microb Pathog. 2023 Jun;179:106080. doi: 10.1016/j.micpath.2023.106080. Epub 2023 Mar 21.
6
Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Patients Undergoing Maintenance Hemodialysis.
Cureus. 2022 May 7;14(5):e24794. doi: 10.7759/cureus.24794. eCollection 2022 May.
7
Epidemiology of haemodialysis outcomes.
Nat Rev Nephrol. 2022 Jun;18(6):378-395. doi: 10.1038/s41581-022-00542-7. Epub 2022 Feb 22.
8
Global prevalence of hepatitis C in general population: A systematic review and meta-analysis.
Travel Med Infect Dis. 2022 Mar-Apr;46:102255. doi: 10.1016/j.tmaid.2022.102255. Epub 2022 Jan 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验